ASHLEY PUNCHES: Open Payments
NPI 1396255352 · BRIGHTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,230 in 68 payments from 18 companies in 2025. Trend: 2023 $1,200 · 2024 $1,266 · 2025 $1,230
Food & beverage: $1,230
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 6 | $138 |
| Tris Pharma Inc | 6 | $126 |
| ABBVIE INC. | 5 | $109 |
| Noven Therapeutics, LLC | 6 | $98 |
| Alkermes, Inc. | 4 | $95 |
| Corium, LLC | 10 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $72 |
| Almatica Pharma LLC | 4 | $66 |
| Vanda Pharmaceuticals Inc. | 3 | $66 |
Products named: REXULTI, VRAYLAR, Dyanavel XR, Xelstrym, ARISTADA, Azstarys, CAPLYTA, TRINTELLIX.
Industry payments across MI — which companies pay providers there.
